Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS) SHH

4.59

+0.42(+10.07%)

Updated at August 19 11:30AM

Currency In CNY

Valuation

Market Cap2.81B
Enterprise Value3B
P/E Ratio-13.21
PEG Ratio-0.75
Price/Sales Ratio1.63
Price/Book Ratio1.37
Enterprise/Revenue1.74
Enterprise/EBITDA-18.77

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.12
Operating Margin-0.12

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.1

Income Statement

Revenue2.17B
Revenue/Share2.68
Gross Profit1.34B
EBITDA-113.44M
Net Income-317.22M
Diluted EPS-0.4

Balance Sheet

Total Cash457.07M
Total Cash/Share0.63
Total Debt676.72M
Total Debt/Equity0.27
Current Ratio1.84
Book Value Per Share3.32

Price History

52-Week Change37.97
52-Week High4.65
52-Week Low2.93
Moving Average 50 Days4.11
Moving Average 200 Days3.8

Statistics

Average Volume19.13M
Shares Outstanding784.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.33
Last Split Factor2:1
Last Split DateJuly 16, 2015